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Regional coronary flow reserve and regional myocardial
contractility were evaluated in 29 patients after maximal
pharmacologic coronary vasodilation (intravenous di-
pyridamole, 0.56 mg/kg body weight, administered over
4 minutes). Nineteen patients had a severe (80 to 99%)
proximal and isolated stenosis of the left anterior de-
scending coronary artery and 10 patients had normal
coronary arteries; all had normal ventricular function
under rest conditions. Myocardial contractility was as-
sessed by means of continuous two-dimensional echo-
cardiographic monitoring; coronary reserve was eval-
uated by coronary sinus thermodilution.
After dipyridamole infusion, 9 of the 19patients with
left anterior descending artery stenosis had transient
myocardial asynergy involving the septum or apex, or
both (Group IA), whereas 10 patients showed no asyn-
ergy (Group 18). No impairment of contractility was
observed in the 10 patients with normal coronary ar-
teries (Group II). Coronary blood flow was measured
Dipyridamole infusion may provoke regional myocardial
asynergy in patients with significant coronary artery disease.
The identification of such asynergy can be obtained by two-
dimensional echocardiographic monitoring combined with
dipyridamole infusion. The dipyridamole echocardiographic
test has been proposed as a feasible and reliable provocative
test for myocardial ischemia secondary to coronary artery
disease (1). A critical stenosis is consistently found in the
coronary artery supplying the region becoming asynergic
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under basal conditions and up to 10 minutes after the
end of dipyridamole infusion. In patients in Group II,
dipyridamole induced an increase in great cardiac vein
flow of 167 ± 68% (mean ± SD). The 10 patients in
Group 18 showed a response comparable with that of
the control group (Group II) (136 ± 45% increase in
great cardiac vein flow; NS versus Group II), whereas
the 9 patients in Group IA had an increase of 46 ± 30%
(p < 0.01 versus both Group IB and Group II). No
significant difference was found in the angiographic se-
verity of the stenosisexpressed in terms of minimal cross-
sectional area (Group IA = 0.30 ± 0.13 mm", Group
18 =0.34 ± 0.18 mm'; p = NS).
In conclusion, coronary artery stenoses of similar an-
giographic severity may produce different reductions in
coronary reserve. The impairment in myocardial con-
tractility after dipyridamole infusion identifies patients
with a critical reduction in regional coronary reserve.
(J Am Coil CardioI1986;8:84-90)
after dipyridamole infusion. However, myocardial regions
supplied by coronary arteries affected by stenoses of similar
angiographic severity may show different contractile pat-
terns after dipyridamole administration (that is, with or with-
out the development of regional asynergy). This might be
due to the inadequacy of angiography to detect patients with
reduced coronary reserve (2).
The aim of this study was to assess whether the different
mechanical effects of intravenous dipyridamole-in patients
with stenoses of comparable severity- were correlated with
regional coronary blood flow reserve (evaluated by means
of coronary sinus blood flow measurements). The fact that
coronary sinus thermodilution provides reliable measure-
ments of regional corona ry blood flow only from the anterior
district (great cardiac blood flow) (3) restricted the select ion
criteria to patients with left anterior descending coronary
artery disease.
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Methods
Study patients. Twenty-two men and seven women (mean
age 48 years, range 35 to 62) who underwent diagnostic
coronary arteriography for a chest pain syndrome were in-
cluded in the study. Nineteen patients presented with prox-
imal and isolated stenosis of the left anterior descending
coronary artery (Group I) and 10 patients had normal coro-
nary arteries (Group II). No patient had previous myocardial
infarction or regional asynergy on left ventriculography and
echocardiography under rest conditions. All medication had
been withheld for at least 3 days before the dipyridamole
echocardiographic test and cardiac catheterization (no pa-
tient was receiving beta-receptor blocking therapy). Because
left ventricular hypertrophy can independently alter the hy-
peremic response of coronary resistance vessels (4), patients
with hypertension, valvular heart disease or evidence of left
ventricular hypertrophy by echocardiography, left ventric-
ulography or electrocardiography were not included.
Dipyridamole echocardiographic test. This test was
performed in all patients before cardiac catheterization as
part of the routine diagnostic work-Up, Dipyridamole (0.56
mg/kg body weight) was administered intravenously over 4
minutes (5,6); a 12 lead electrocardiogram and blood pres-
sure measurement (by cuff sphygmomanometer) were ob-
tained at baseline and every minute throughout the test.
Two-dimensional echocardiograms were continuously re-
corded during and up to 20 minutes after the end of dipyr-
idamole administration. A commercially available wide an-
gle, phased array imaging system (Hewlett-Packard, model
77020, 3.5 and 5.0 MHz transducers) was used. In the
baseline studies, all standard echocardiographic views (para-
sternal and subxiphoid long-axis and short-axis, apical four
chamber and two chamber) were obtained when possible.
During the test, new areas of abnormal wall motion were
identified on multiple views by rapidly moving the ultra-
sound transducer through various positions. When the op-
timal position for observing abnormal wall motion was es-
tablished, the transducer was kept steady throughout the
study.
The videotapes were analyzed by two independent ob-
servers who did not have access to the cardiac catheterization
findings until after the analysis. Segmental anatomy and
wall motion were assessed in a qualitative manner as pre-
viously reported (1). Wall motion was graded as hyperki-
netic, normal, hypokinetic, akinetic or dyskinetic. For pur-
poses of analysis, the left ventricle was divided into four
segments in each of the major echocardiographic views:
septum, anterolateral wall, inferoposterior wall and apex
(I). In each study wall motion was assessed at baseline and
at peak changes after dipyridamole infusion. Each observer
also recorded the time of occurrence of changes in myo-
cardial contraction. The extension, grading and timing of
asynergy were determined by consensus.
Hemodynamic study. The average time delay between
the dipyridamole echocardiographic test and cardiac cath-
eterization was 2 days (range I to 4). Cardiac catheterization
was performed with the patients in the fasting state; intra-
muscular diazepam (10 mg) was administered 60 minutes
before the procedure. Biplane left ventriculography and se-
lective coronary arteriography were performed using the
Judkins technique. MUltiple projections, including cranio-
caudal views, were obtained in all patients. Cineangiograms
were recorded on videotape (Sirecord XS, Siemens) and
reviewed to verify whether the patient met the inclusion
criteria (severe, proximal, isolated left anterior descending
coronary artery stenosis; absence of regional wall motion
abnormalities). The Judkins catheter was left in the aortic
root for pressure measurements.
A Pepine three-thermistors thermodilution catheter (Wil-
ton Webster Laboratories), introduced through a median
basilic vein, was advanced into the coronary sinus up to the
great cardiac vein for simultaneous great cardiac vein and
coronary sinus flow determinations (3,7). Contrast medium
was injected through this catheter to ensure proper location.
The distal thermistor was placed in the great cardiac vein
upstream to the entrance of any marginal vein into the coro-
nary sinus. The catheter was then secured to the forearm
with plaster to limit the risk of displacement during the
study. Twenty minutes after the end of coronary arteriog-
raphy, an electrocardiogram and simultaneous aortic pres-
sure, and coronary sinus and great cardiac vein blood flow
determinations were obtained in duplicate. After the second
measurement, dipyridamole (0.56 mg/kg over 4 minutes)
was injected intravenously. Measurements were then re-
peated every 2 minutes for 10 minutes after the end of the
infusion.
Hemodynamic measurements. Aortic pressure was
measured by a P23 DB Statham pressure transducer. Coro-
nary sinus and great cardiac vein flows were calculated
according to the method of Ganz et al. (8). The injectate
was normal saline solution at room temperature, delivered
by a Harvard pump at a flow rate of 46.8 mllmin. Recording
was made at a paper speed of 10 mm/s, with brief intervals
at 25 mm/s. Great cardiac vein flow was assumed to rep-
resent venous outflow from the left anterior descending ar-
tery territory (3,7). We measured percent changes in great
cardiac vein flow using each patient as his or her own con-
trol.
Angiographic assessment of coronary stenosis. Each
coronary artery was viewed in multiple projections. Coro-
nary cineangiograms, recorded on 35 mm films, were re-
viewed on a Tagarno projector. In each patient, end-diastolic
frames from two complementary views were selected. The
selected frames were projected onto a horizontal screen by
a photographic enlarger (DURST M800), using a constant
enlargement factor of 11 times the frame size. The stenoses,
as well as the pre- and poststenotic tracts and a portion of
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Table 1. Clinical and Coronary Hemodynamic Findings in 29 Patients
Basal Dipyridamole
GCV
History of GCV Flow CVR Ant Flow GCV % CVR Ant CVR Ant % Time
Case Sex Smoking (ml/min) (mm Hg/ml per min) (mllmin) Increase (mm Hg/m1 per min) Decrease (min) DET
Group IA (LAD stenosis with asynergy)
I M Yes 110 0.78 140 27 0.56 28 2 +
2 M No 98 0.96 113 15 0.86 10 4 +
3 M Yes 67 1.25 96 41 0.88 30 4 +
4 F No 54 1.87 73 35 1.4 25 2 +
5 M No 125 0.9 191 53 0.6 33 2 +
6 M Yes 61 1.77 117 92 1.07 40 4 +
7 F No 28 3.82 54 93 2.30 40 4 +
8 M Yes 81 1.14 95 17 1.03 10 2 +
9 M Yes 42 2.09 58 38 1.3 38 6 +
Mean 74.1 1.62 104.1 45.8 1.11 28.1 3.3
± SO 32.2 0.95 43.1 29.9 0.53 11.5 1.4
Group IB (LAD stenosis without asynergy)
10 M No 107 0.96 258 139 0.34 65 2
11 M Yes 53 1.45 112 III 0.78 46 2
12 M No 65 1.8 132 103 0.88 51 4
13 M No 103 1.12 263 155 0.38 66 2
14 M No 113 0.82 209 85 0.42 49 6
15 M Yes 62 1.47 160 158 0.61 59 6
16 M Yes 68 1.67 222 227 0.37 78 4
17 M No 75 1.33 154 105 0.57 57 4
18 M Yes 54 1.76 91 69 0.9 49 2
19 F No 102 0.97 262 157 0.36 63 2
Mean 80.1 1.34 186.2 135.7 0.56 58.2 3.4
± SO 23.5 0.35 64.7 45.1 0.22 9.9 1.7
Group II (normal coronary arteries)
20 F No 39 2.7 94 141 1.0 63 2
21 M Yes 42 2.1 130 210 0.65 69 2
22 M No 71 1.2 155 118 0.53 56 2
23 F No 105 0.93 215 105 0.44 53 2
24 F No 68 1.43 225 231 0.39 73 4
25 M Yes 60 1.79 202 237 0.45 75 2
26 M No 87 1.3 284 226 0.37 72 2
27 M Yes 53 1.59 179 237 0.44 72 4
28 F Yes 70 1.28 119 70 0.61 52 2
29 M Yes 59 1.5 112 90 0.7 53 2
Mean 65.4 1.58 171.5 166.5 0.56 63.7 2.4
± SO 19.9 0.48 60.3 67.9 0.18 8.9 0.8
CVR Ant = anterior coronary vascular resistance; DET = result of dipyridamole echocardiographic test (+ = positive, - = negative); F =
female; GCV Flow = great cardiac vein flow; LAD = left anterior descending coronary artery; M = male; Time = time of maximal flow changes
after dipyridamole.
the catheter near its tip, were carefully traced. Measure- Validation of quantitative coronary arteriography.
ments were performed by means of a magnifying glass pro- To test the reproducibility of the method, the same observer
vided with a scale in tenths of millimeters. Values were repeated the procedure of tracing and measuring the di-
then elaborated by means of a computer program to correct ameters of the "normal" and the stenotic portion of the
data for magnification and to calculate the cross-sectional selected vessel from the 19 patients in Group I. Intraobserver
area of the apparently normal portion of the vessel, the variability was 5.5% (SEE). The procedure was also per-
minimal cross-sectional area (assuming an elliptical vessel formed by a second observer on the same group of coronary
cross section), the percent stenosis diameter in both right artery segments. Interobserver variability was 7.6% (SEE).
anterior oblique and left anterior oblique views and the Statistical analysis. Values are expressed as mean ±
percent area stenosis. SD. Intergroup differences were tested for significance by
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DET + DET - CONTROL S
DET = dipyridamole echocardiographic test; ECG = electrocardio-
gram; EST = exercise stress test; RPP = rate-pressure product ( x 1/100)
at ischemia (1.5 mm of ST segment depression) or maximal (when neg-
ative) .
stenosis defined as percent diameter reduction (Group IA
= 90 ± 6%, Group IB = 88 ± 6%; P = NS), percent
area stenosis (Group IA = 96.6 ± 1.6%, Group IB =
95.6 ± 2.6%; P = NS) or minimal cross-sectional area
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Figure 1. The increment in great cardiac vein flow (mean ± SD)
after dipyridamole infusion is shown for the three groups. The
increase is blunted in the group with dipyridamole-induced asyn-
ergy (DET+)compared with that in the other two groups (DET-
and control subjects).
Case
Table 2. Exercise Stress Test and Dipyridamole
Echocardiographic Test Findings in the 19 Patients With
Coronary Artery Disease
Results
The effects of intravenous dipyridamole on left ventric-
ular function, great cardiac vein flow and anterior coronary
resistance in each patient are shown in Table 1.
Echocardiographic findings. The interpretation of the
dipyridamole echocardiographic test was unanimous in all
29 cases . All patients with normal coronary arteries (Group
II) showed a transient hyperkinetic phase involving all re-
gions of both right and left ventricles, reaching its peak 0
to 4 minutes after the end of dipyridamole infusion. In all,
wall motion reverted to normal within 10 to 15 minutes after
the end of the infusion. None had chest pain or electrocar-
diographic changes after dipyridamole . All of these patients
had a negative exercise stress test.
In Group I (patients with left anterior descending coro-
nary artery stenosis) , immediately after the hyperkinetic
phase (appearing 0 to 3 minutes after the end of the infu-
sion), nine patients (Group IA) showed transient asynergy
of contraction , consisting of akinesia in seven and hypo-
kinesia in two. The asynergy always involved the left an-
terior descending artery territory. appearing more obvious
in the septum (eight patients) or anteroapical wall (one pa-
tient). Asynergy was detectable 2 to 5 minutes after the end
of the infusion . Of these nine patients, eight had chest pain
and eight had diagnostic (> 1.5 mY) ST segment depression
on the electrocardiogram (Table 2). Seven of these patients
also had a positive exercise stress test (for electrocardio-
graphic criteria).
The remaining 10 patients with left anterior descending
artery stenosis (Group IB) showed myocardial mechanical
behavior similar to that of Group ll, that is, an early hy-
perkinetic phase slowly reverting to normal contraction .
without ever showing asynergy . Of these 10 patients , 4 had
chest pain after dipyridamole (Table 2); 3 of these had a
positive exercise stress test (for electrocardiographic cri-
teria).
Coronary hemodynamic findings. The increase in great
cardiac vein flow in Group IA ( + 46 ± 30%) was signif-
icantly smaller (p < 0.01) than that in either Group IB
( + 136 ± 45%)orGroupIl (+167 ± 68%) (Fig. l ). The
decrease in coronary resistance in the anterior district was
significantly smaller in Group IA (- 28 ± 11%) than in
Group IB (-58 ± 10%) or Group II (-64 ± 9%).
Coronary angiographic findings. No significant dif-
ference between Groups IA and IB was found in the an-
giographic severity of the left anterior descending artery
analysis of variance with subgroup analysis according to the
Neumann-Keuls test. Within each group, differences in
hemodynamic variables from the basal state were tested with
the paired Student t test. Differences in angiographic and
coronary hemodynamic variables were tested with the un-
paired Student t test.
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Table3. Coronary Angiographic Findings
LAD LAD LAD Minimal Collaleral
% Diameter % Area Cross-Sectional Circulation Dominant
Case Stenosis Stenosis Area (mrrr') Present Vessel
Group IA
I 90 97 0.29 No LCx
2 98 99 0.10 Yes RCA
3 87 95 0.32 Yes RCA
4 90 96 0.44 Yes RCA
5 85 95 0.35 Yes RCA
6 80 96 0.27 No LCx
7 91 97 0.33 No RCA
8 98 99 0.11 Yes RCA
9 89 95 0.51 No RCA
Mean 90 96.6 0.30
± SD 6 1.6 0.13
Group IB
10 98 99 0.13 Yes RCA
II 80 91 0.40 No RCA
12 80 92 0.48 No RCA
13 86 95 0.62 No RCA
14 98 98 0.11 Yes RCA
15 88 96 0.27 No RCA
16 90 96 0.19 No RCA
17 89 91 0.50 No RCA
18 86 99 0.34 No LCx
19 86 93 0.35 No RCA
Mean 88.0 95.6 0.34
± SD 6 2.6 0.18
Group II
20 No RCA
21 No RCA
22 No RCA
23 No LCx
24 No RCA
25 No RCA
26 No RCA
27 No RCA
28 No RCA
29 No RCA
LAD = left anterior descending artery; LCx = left circumflex artery; RCA = right coronary artery.
Table 4. Hemodynamic Findings in 29 Patients
Patients With Coronary Artery Disease
Positive DET
(Group IA)
Negative DET
(Group IB)
Control Subjects
(Group II)
Basal Maximal Basal Maximal Basal Maximal
Heart rate (beats/min)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Rate-pressure product (X 1(0)
(mm Hg x beats/min)
80 + 19
140 + 15
79 + 5
112 + 19
110 + lOt
145 + 13
85 + 13
159 + 25t
67 + 10
147 + 14
81 + 9
99 + 19
98 + 14t
138 + 19
69 + 16*
135 + 19t
75 + 13
136 + 16
78 + 12
105 + 13
107 + I7t
120 + 13*
65 + 12*
139 + 27t
*p < 0.05; tp < 0.01. Asynergy = onset of asynergy; maximal = maximal hemodynamic changes. Significance is compared with basal. Abbreviations
as in Table I.
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(Group IA = 0.30 ± 0.13 mm", Group IB = 0.34 ± 0.18
mm"; p = NS) (Table 3). The coronary dominance pattern
and the presence of collateral circulation in each patient are
reported in Table 3.
Hemodynamic findings. Changes in heart rate, systolic
and diastolic pressures and rate-pressure product were sim-
ilar in the three groups (Table 4).
History of cigarette smoking. Five patients in Group
lA, four in Group IB and five in Group II had a history of
chronic cigarette smoking (more than one pack daily for at
least 5 years) (Table 1), a fact that might in itself restrict
coronary reserve (9). All patients had stopped smoking at
least 6 days before entering the study.
Discussion
Angiographic responses to dipyridamole infusion. The
10 subjects with normal coronary arteries (Group II) showed
a homogeneous response to dipyridamole infusion, con-
sisting of a reduction in coronary resistance, an increase in
coronary blood flow and transient hyperkinesia of all ven-
tricular walls. In contrast, the 19 patients with a severe
proximal stenosis presented with two different mechanical
responses to dipyridamole, corresponding to two different
flow patterns. Ten patients (Group IB) showed hyperkinesia
paralleled by an increase in regional coronary blood flow
comparable with that of normal subjects, whereas the other
9 (Group IA), with apparently similar coronary anatomy
but severe limitation in coronary reserve, had a positive
dipyridamole echocardiographic test. These findings are
consistent with studies in human subjects-performed with
a Doppler device-demonstrating that the physiologic ef-
fects of coronary obstructions cannot be determined with
accuracy by conventional angiographic approaches (2), or
even by quantitative angiography (10).
Echocardiographic responses to dipyridamole infu-
sion. The observations of our study suggest that the di-
pyridamole echocardiographic test could discriminate be-
tween coronary artery lesions with similar angiographic
appearance but prominent hemodynamic differences. Con-
tinuous echocardiographic monitoring during dipyridamole
infusion can demonstrate alterations in myocardial function
to be regarded as a manifestation of reduced regional flow
reserve, The lack of correlation between mechanical dys-
function and angiographic severity of the lesion could still
be due in part to incomplete quantitative coronary analysis,
because we did not take into account the composite inte-
grated effects of blood viscosity, lesion length, absolute
diameter and percent narrowing combined (11).
Mechanism of positive dipyridamole echocardio-
graphic test. Patients with a positive dipyridamole echo-
cardiographic test exhibited the mechanical manifestation
of ischemia (regional asynergy). In these patients, myo-
cardial metabolic demands (estimated by rate-pressure prod-
uct) were only slightly increased; anterior coronary flow
was also increased, although much less than in patients with
normal coronary arteries or patients with coronary disease
and a negative dipyridamole echocardiographic test. These
data could confirm the hypothesized mechanism of "vertical
steal" occurring in patients with single vessel disease and
dipyridamole-induced ischemia (12). The increase in the
transstenotic gradient as a consequence of the increase in
flow (13) and the decrease in aortic pressure might ultimately
lead to subendocardial ischemia, with the extra flow shunted
away through the pharmacologically dilated subepicardial
vascular bed. The small increase in great cardiac vein flow
observed in patients with a positive dipyridamole echocar-
diographic test does not contradict this hypothesis, because
within the territory dependent on the left anterior descending
artery, areas with increased perfusion (mostly subepicar-
dium) coexist with areas with decreased perfusion (mostly
subendocardium) (14).
Visible collateral vessels were observed more frequently
in patients with a positive dipyridamole echocardiographic
test (5 of 9) than in those with a negative test (2 of 10). It
seems clear, therefore, that collateral vessels cannot prevent
dipyridamole-induced ischemia. Their prevalence in the
positive dipyridamole echocardiographic test group might
either indicate a physiologically more severe stenosis or
represent the anatomic background facilitating "horizontal
steal" phenomena between adjacent vascular beds (12).
Conclusions. The dipyridamole echocardiographic test
provides relevant additions to the anatomic information ob-
tained by coronary angiography. The mechanical behavior
of the left ventricle after dipyridamole administration better
reflects the physiologic consequence of the stenosis than its
angiographic severity, assessed either as percent luminal
reduction or as minimal cross-sectional area.
We are grateful to Claudio Michelassi for statistical advice.
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